Markets Stocks Economy Crypto Earnings Banking Energy
Home Tech Feature
Tech · Exclusive

Apple's $1,999 iPhone Duo marks its first foldable, with new Pro models and AirPods

Apple's $1,999 iPhone Duo marks its first foldable, with new Pro models and AirPods
Tech · 2026
Photo · Eleanor Whitfield for Daily Digest Invest
By Eleanor Whitfield Markets Editor-in-Chief Sep 9, 2026 5 min read

Apple has officially entered the foldable smartphone race. The company unveiled the iPhone Duo, its first foldable device, priced at $1,999, alongside a refreshed lineup that includes the iPhone 18 Pro models and the new AirPods 5 with active noise cancellation at $129. The products will roll out between September and October, giving Apple a shot at reviving a category that has so far been dominated by rivals like Samsung and Huawei.

A new form factor, a familiar price premium

The iPhone Duo is Apple's boldest hardware bet in years. Foldables have been around for a while, but they've remained a niche—expensive, heavy, and sometimes fragile. Apple's entry could change that, much like it did with the original iPhone, the iPad, and the Apple Watch. The $1,999 price tag puts the Duo squarely in ultra-premium territory, above even the most expensive iPhone 18 Pro models. That's a deliberate move: Apple is testing whether its loyal customer base will pay a significant premium for a new form factor.

For context, the current iPhone lineup starts well below that, with standard models typically in the $800–$1,200 range. The Duo's price is closer to what you'd pay for a high-end laptop. But Apple has a history of commanding premium prices, and its ecosystem—iMessage, iCloud, the App Store—gives it a moat that competitors struggle to match.

What else is new

Alongside the Duo, Apple refreshed its Pro line with the iPhone 18 Pro and Pro Max. These are expected to be iterative upgrades—better cameras, faster chips, maybe improved battery life—but they remain the bread-and-butter for most iPhone buyers. The AirPods 5, at $129, bring active noise cancellation (ANC) to a more accessible price point. ANC, which uses microphones to cancel out background noise, was once a premium feature; now it's becoming standard even in mid-range earbuds. That could pressure competitors like Samsung and Sony, who have dominated the wireless earbud market.

Apple also announced new Apple Watches, though details were thin in the initial announcement. The company typically refreshes its wearables alongside the iPhone, and this year is no exception.

The bigger picture: a test for Apple's next era

This launch comes at a pivotal moment for Apple. The company has been criticized for a lack of innovation in recent years, with incremental iPhone updates and a mixed track record in new categories like the Vision Pro headset. The foldable iPhone is a chance to change that narrative. It's also a test for John Ternus, Apple's hardware chief, who is widely seen as a potential successor to CEO Tim Cook. Ternus is in the spotlight as he leads the company into this new form factor.

The foldable market itself has been struggling. Global shipments have grown, but not as fast as early optimists predicted. High prices and durability concerns have kept many consumers on the sidelines. Apple's entry could give the category a jolt, much like it did with smartwatches. Some analysts believe this could revive the foldable market, which has been waiting for a mainstream catalyst.

What it means for investors

For everyday investors, the key question is whether the iPhone Duo will drive meaningful revenue growth. Apple's iPhone sales have been relatively flat in recent years, and the company has leaned on services like Apple Music and iCloud for growth. A successful foldable could reignite hardware sales and boost average selling prices, which is good for margins. But it's not a sure thing.

The $1,999 price point is a double-edged sword. On one hand, it could generate significant revenue per unit. On the other, it limits the addressable market. Most consumers won't spend $2,000 on a phone, no matter how innovative. Apple knows this, which is why it's likely positioning the Duo as a halo product—something that generates buzz and pulls people into the ecosystem, even if they buy a cheaper iPhone 18 Pro instead.

Investors should also watch the competitive response. Huawei recently launched its own foldable, the Mate XT2, with an in-house chip, signaling that the rivalry in this space is heating up. Samsung has been selling foldables for years. Apple's entry doesn't guarantee dominance, but it does validate the category.

Risks and watch items

There are a few things to keep an eye on. First, supply chain constraints. Foldable screens are complex to manufacture, and Apple has reportedly faced production challenges. Any delays could push the October rollout and hurt holiday-quarter sales. Second, durability. Early foldables had issues with creases and screen failures. Apple will need to convince consumers that the Duo is built to last. Third, the price. If the Duo doesn't sell well, it could be seen as a misstep, especially with two big tests on the horizon: the foldable and a smarter Siri.

For now, the announcement is a positive signal. Apple is taking risks again, and that's something investors have wanted to see. The real test will come when the first sales numbers land in the coming months. If the Duo sells out, expect the stock to get a boost. If it fizzles, the narrative of Apple as a mature, slow-growth company will only strengthen.

The bottom line

Apple's first foldable iPhone is a big deal—not just for Apple, but for the entire smartphone industry. It's a chance for the company to prove it can still innovate, and for investors, it's a potential catalyst. But with a $1,999 price tag and a crowded competitive field, the outcome is far from certain. As always, the numbers will tell the story.

More from this story

Next article · Don't miss

UBS sees Thermo Fisher and Danaher returning to steady growth

UBS analysts predict Thermo Fisher and Danaher will return to mid-single-digit organic revenue growth next year. The recovery is expected as bioprocessing demand steadies and China's market stabilizes, offering a brighter outlook for life sciences investors.

Read the story →
UBS sees Thermo Fisher and Danaher returning to steady growth